Flavonoids, flavonoid subclasses and breast cancer risk: a meta-analysis of epidemiologic studies - PubMed (original) (raw)

Meta-Analysis

Flavonoids, flavonoid subclasses and breast cancer risk: a meta-analysis of epidemiologic studies

Chang Hui et al. PLoS One. 2013.

Abstract

Background: Studies have suggested the chemopreventive effects of flavonoids on carcinogenesis. Yet numbers of epidemiologic studies assessing dietary flavonoids and breast cancer risk have yielded inconsistent results. The association between flavonoids, flavonoid subclasses (flavonols, flavan-3-ols, etc.) and the risk of breast cancer lacks systematic analysis.

Objective: We aimed to examine the association between flavonoids, each flavonoid subclass (except isoflavones) and the risk of breast cancer by conducting a meta-analysis.

Design: We searched for all relevant studies with a prospective cohort or case-control study design published before July 1(st), 2012, using Cochrane library, MEDLINE, EMBASE and PUBMED. Summary relative risks (RR) were calculated using fixed- or random-effects models. All analyses were performed using STATA version 10.0.

Results: Twelve studies were included, involving 9 513 cases and 181 906 controls, six of which were prospective cohort studies, and six were case-control studies. We calculated the summary RRs of breast cancer risk for the highest vs lowest categories of each flavonoid subclass respectively. The risk of breast cancer significantly decreased in women with high intake of flavonols (RR=0.88, 95% CI 0.80-0.98) and flavones (RR=0.83, 95% CI: 0.76-0.91) compared with that in those with low intake of flavonols and flavones. However, no significant association of flavan-3-ols (RR=0.93, 95% CI: 0.84-1.02), flavanones (summary RR=0.95, 95% CI: 0.88-1.03), anthocyanins (summary RR=0.97, 95% CI: 0.87-1.08) or total flavonoids (summary RR=0.98, 95% CI: 0.86-1.12) intake with breast cancer risk was observed. Furthermore, summary RRs of 3 case-control studies stratified by menopausal status suggested flavonols, flavones or flavan-3-ols intake is associated with a significant reduced risk of breast cancer in post-menopausal while not in pre-menopausal women.

Conclusions: The present study suggests the intake of flavonols and flavones, but not other flavonoid subclasses or total flavonoids, is associated with a decreased risk of breast cancer, especially among post-menopausal women.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors declare that they have no competing interests.

Figures

Similar articles

Cited by

References

    1. Ferlay J, Shin H, Bray F, Forman D, Mathers C, et al... (2010) GLOBOCAN 2008: cancer incidence and mortality worldwide. In: IARC CancerBase No. 10 (version 2.0). Lyon: IARC.
    1. Youlden DR, Cramb SM, Dunn NA, Muller JM, Pyke CM, et al. (2012) The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol 36: 237–48. - PubMed
    1. American Cancer Society Global cancer facts and figures (2007) American Cancer Society, Atlanta.
    1. National Cancer Institute (NCI), US Department of Health and Human Services (2006) The NCI Strategic Plan for Leading the Nation to Eliminate the Suffering and Death Due to Cancer. Bethesda, MD: NCI.
    1. American Institute for Cancer Research (AICR) and World Cancer Research Fund (WCRF). Policy and Action for Cancer Prevention. Washington, DC: AICR/WCRF; 2009.

Publication types

MeSH terms

Substances

LinkOut - more resources